 |
| juLY
8, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
 |
BIG4BIO
CEO WEEKLY Q&A:
Jehee Suh, CEO, Inocras |
| In this
Q&A, Suh discusses what drew him to
Inocras, why whole-genome analysis is
approaching an inflection point, how
Inocras is building the evidence base for
broader clinical adoption, and what it
will take for whole-genome-based care to
become the new standard in oncology and
rare disease. More |
|
|
- Angel
Aligner: Launches iOrtho Release 6.2, Bringing
Deeper Diagnostics, Smarter Prescriptions, and
Faster Planning to Orthodontists Nationwide More
- Arcutis:
FDA Accepts Supplemental New Drug Application
for ZORYVE (roflumilast) Cream 0.05% for the
Treatment of Mild to Moderate Atopic
Dermatitis in Infants Down to 3 Months More
- Johnson
& Johnson: FDA Approval for the Dual
Energy THERMOCOOL SMARTTOUCH SF Platform More
- Niagen
Bioscience: Launches Pharmaceutical Program
for Accelerated Aging and Rare Genetic
Diseases More
- Orange
County Urology Associates: Francis Medical
Announces Orange County Urology Associates
Becomes First in California to Integrate
Vanquish Water Vapor Ablation Into Routine
Prostate Care More
- TLI:
Showcases Global Health Research During Gates
Foundation Campus Visit More
- UCI:
A New Era of Precision Depression Treatment
More
- UCLA
Health: Can Digital Alerts Curb Antipsychotic
Prescribing in Dementia Care? More
|
|
- BioPharmCatalyst
Weekly Watchlist: Key PDUFA and Regulatory
Catalysts for the Next 6 Months More
- Why
Is Turn Therapeutics Stock Trading Higher
Today? More*
|
|
- A Decade on the Map: How Big4Bio’s
Regions Moved in GEN’s Top 10 Biopharma
Clusters, 2016–2026
More
- Allergan Aesthetics Helps Map Paths for
Young Women in Stem With Girls Inc Event More
- Big4Bio CEO Weekly Q&A: Jehee
Suh, CEO, Inocras More
- More on Beckman Coulter p-Tau217 Blood Test
Getting CE-IVDR Mark More*
- Subscribe to LifeSci Startup for
Updates on US Startups More
- ZoBio: Expert
Q&A More
|
|
-
|
| Life
Sciences Talent and Consulting
Strategist George Quinn Named
Partner, Fractional Talent at
Slone Partners |
|
Learn More
→ |
|
|
- ICYMI: A View From the Trenches - Biotech
Series A in 2026 More
- ICYMI: Caltech Appoints Julie Messersmith as
Vice President for Institute Initiatives More
- ICYMI: UCI Health Appoints Neuro-Oncologist
Dr. Frances Chow to Lead the Comprehensive
Brain Tumor Program More
- OPPORTUNITY: Chief Executive Officer,
Cambridge, MA More
- OPPORTUNITY: Chief Financial Officer, Pine
Brook, NJ / Hybrid More
- OPPORTUNITY: Vice President, Global BD,
Remote More
- Slone Partners: How to De-Risk
Executive Hiring Decisions in Life Sciences
and Healthcare More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Los Angeles Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Los
Angeles, all rights reserved
2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
